Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762275019 | Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3762276018 | Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | Loteprednol etabonate + tobramycin | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has active ingredient | Tobramycin (substance) | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has active ingredient | Loteprednol etabonate (substance) | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | Loteprednol etabonate ophthalmic preparation | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | Product containing tobramycin in ophthalmic dosage form | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has manufactured dose form | Eye suspension | true | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | Product containing loteprednol and tobramycin (medicinal product) | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | Product containing loteprednol in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | Loteprednol and tobramycin only product in ocular dose form | true | Inferred relationship | Some | ||
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has precise active ingredient | Loteprednol etabonate (substance) | true | Inferred relationship | Some | 2 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has precise active ingredient | Tobramycin (substance) | true | Inferred relationship | Some | 1 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has basis of strength substance (attribute) | Tobramycin (substance) | true | Inferred relationship | Some | 1 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength numerator value | 5 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has concentration strength numerator value | 3 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Has basis of strength substance (attribute) | Loteprednol etabonate (substance) | true | Inferred relationship | Some | 2 | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR